MedPath

Phenazopyridine

Generic Name
Phenazopyridine
Brand Names
Phenazo, Pyridium, Uristat, Urobiotic
Drug Type
Small Molecule
Chemical Formula
C11H11N5
CAS Number
94-78-0
Unique Ingredient Identifier
K2J09EMJ52
Background

Phenazopyridine, also known as Pyridium, is a urinary tract analgesic used for the short-term management of urinary tract irritation and its associated unpleasant symptoms such as burning and pain during urination. In the USA, this drug was previously marked by Roche but has been discontinued by the FDA. It is still used in various parts of the world. Ingestion of phenazopyridine is found to change the appearance of the urine by imparting an orange or red color, as it is considered an azo dye.

Indication

Phenazopyridine hydrochloride is indicated to relieve uncomfortable symptoms that occur as a consequence of mucosal irritation of the lower urinary tract in adults. The irritation may be a result of trauma, surgery, endoscopic procedures, infection, or the insertion of instruments or urinary catheters. Phenazopyridine may be used in combination with antimicrobial therapy but is not used as an antimicrobial agent. It contributes to the relief of discomfort and pain before antimicrobial therapy begins to take effect. It is important to note that the duration of treatment with this drug should last a maximum of 2 days. Phenazopyridine is available in many countries as an over the counter drug.

Associated Conditions
Lower Urinary Tract Infection, Signs or symptoms of urinary tract irritation

Evaluation of Ureteral Patency in the Post-indigo Carmine Era

Phase 4
Completed
Conditions
Ureteral Patency
Interventions
First Posted Date
2016-02-09
Last Posted Date
2019-05-30
Lead Sponsor
Columbia University
Target Recruit Count
140
Registration Number
NCT02677623
Locations
🇺🇸

Columbia University Medical Center, New York, New York, United States

Evaluation of Ureteral Jets on Cystoscopy

Not Applicable
Completed
Conditions
Injury of Ureter
Interventions
Drug: Normal saline
Drug: Dextrose 10%
First Posted Date
2015-06-19
Last Posted Date
2019-10-23
Lead Sponsor
Cecilia Calvo
Target Recruit Count
176
Registration Number
NCT02476448
Locations
🇺🇸

Cleveland Clinic Florida, Weston, Florida, United States

Phenazopyridine for Confirmation of Ureteral Patency

Not Applicable
Completed
Conditions
Cystoscopy
Interventions
First Posted Date
2015-04-22
Last Posted Date
2016-12-05
Lead Sponsor
Hartford Hospital
Target Recruit Count
107
Registration Number
NCT02424149
Locations
🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease

Phase 2
Conditions
Alzheimer's Disease
Mild Cognitive Impairment
MCI
Aging
AD
Interventions
First Posted Date
2015-03-05
Last Posted Date
2022-08-26
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
117
Registration Number
NCT02380573
Locations
🇺🇸

Research Imaging Institute, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria

Phase 3
Completed
Conditions
Dysuria
Interventions
First Posted Date
2012-08-06
Last Posted Date
2020-07-07
Lead Sponsor
EMS
Target Recruit Count
316
Registration Number
NCT01657448
Locations
🇧🇷

Marcio Antonio Pereira Clinica de Endocrinologia, São José dos Campos, São Paulo, Brazil

🇧🇷

Centro de Medicina Reprodutiva Carlos Isaia Filho Ltda, Porto Alegre, Rio Grande Do Sul, Brazil

🇧🇷

AFIP, São Paulo, Brazil

and more 1 locations

Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo

Phase 3
Completed
Conditions
Pain
Urinary Tract Infections
Interventions
First Posted Date
2010-02-08
Last Posted Date
2013-01-29
Lead Sponsor
Amneal Pharmaceuticals, LLC
Target Recruit Count
233
Registration Number
NCT01064024
Locations
🇺🇸

Oxford Pharmaceutical Resources, Inc., Totowa, New Jersey, United States

Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria

Phase 3
Conditions
Dysuria
Interventions
First Posted Date
2009-09-01
Last Posted Date
2009-09-01
Lead Sponsor
Laboratorios Osorio de Moraes Ltda.
Target Recruit Count
80
Registration Number
NCT00969254

CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial

Phase 4
Completed
Conditions
Catheter-related Bladder Discomfort
Interventions
First Posted Date
2008-10-13
Last Posted Date
2016-09-29
Lead Sponsor
Loyola University
Target Recruit Count
258
Registration Number
NCT00771173
Locations
🇺🇸

Loyola Univeristy Medical Center, Maywood, Illinois, United States

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

Not Applicable
Conditions
Human Volunteers
Interventions
First Posted Date
2008-08-29
Last Posted Date
2008-08-29
Lead Sponsor
Universal Enterprises
Target Recruit Count
24
Registration Number
NCT00743977
Locations
🇵🇰

Health Care Hospital, Karachi, Pakistan

© Copyright 2025. All Rights Reserved by MedPath